Germany has introduced a new regulation on crypto fund units.

A company may potentially lose WKSI status upon filing its Form 10-K or Form 20-F. To assist public companies in addressing this issue, we have prepared the following memo on navigating loss of WKSI status.

Given the volume of SEC rulemaking and other corporate governance developments, public companies are frequently looking to understand the current state of play.

The universal proxy rules will apply to all shareholder meetings held on or after September 1, 2022. Last week, the SEC issued three Compliance and Disclosure Interpretations...

We have updated our detailed set of FAQs on the SEC's new pay versus performance rules in an effort to answer the numerous questions we have received from our public company clients over the last few months.

Goodwin Procter helped defeat class certification in three recent cases involving consumer financial services.

The U.S. District Court for the Southern District of New York dismissed an ERISA breach of fiduciary duty action alleging that an investment manager imprudently invested retirement plan assets in mortgage-backed securities.

President Obama recently delivered a draft of his Plan for Economic Growth and Deficit Reduction (the "Debt Reduction Plan") to Congress. The Debt Reduction Plan provides for a steady reduction of the nation’s outstanding debt as a percentage of gross domestic product.

For foreign private issuers (FPIs) with a calendar year-end, now is the time of year to conduct the annual assessment to determine whether the company still qualifies as an FPI.

In this audio discussion, Goodwin lawyers examine disclosure considerations for companies navigating policy shifts as they prepare annual reports and proxy statements.

On April 29, 2024, the U.S Food and Drug Administration (FDA) announced its final rule on Laboratory Developed Tests (LDTs).

My grandparents inspired me to start Koltin. During the COVID-19 pandemic, they were denied access to private health insurance. I investigated, and it turns out insurance for the elderly is inaccessible in Mexico.

The year 2020 was a transformative one for the life sciences industry.

The United States District Court for the District of Maryland partially granted summary judgment in favor of plaintiffs in a class action alleging violations of the Truth in Lending Act.

The U.S. Court of Appeals for the Seventh Circuit recently vacated a trial court’s order certifying a class in an action under the Individuals with Disabilities Education Act (IDEA).

As regular Big Molecule Watch readers know, the Biologics Price Competition and Innovation Act ("BPCIA") was signed into law as part of the Affordable Care Act on March 23, 2010...

As regular Big Molecule Watch readers know, the Biologics Price Competition and Innovation Act ("BPCIA") was signed into law as part of the Affordable Care Act on March 23, 2010...

On September 10, 2025, the SEC announced that an open meeting will be held on September 17, 2025 and the agenda items include...

On October 20, 2025, Teva Pharmaceuticals International GmbH ("Teva") announced a licensing agreement with Prestige BioPharma Ltd. ("Prestige BioPharma") to commercialize TUZNUE® (trastuzumab), a biosimilar to Genentech's HERCEPTIN (trastuzumab), in a majority of European countries.

On December 6, 2025, Vertex Pharmaceuticals Inc. ("Vertex") announced data from several studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel)...